Efmoroctocog alfa
Eloctate, Elocta (efmoroctocog alfa) is a fusion protein pharmaceutical. Efmoroctocog alfa was first approved as Eloctate on 2015-11-18. It has been approved in Europe to treat hemophilia a.
| Trade Name | Elocta |
|---|---|
| Common Name | Efmoroctocog alfa |
| Indication | hemophilia a |
| Drug Class | Fc fusion protein |
